A new sulfonylurea called Amaryl (AM-a-ril, glimepiride)

A new sulfonylurea called Amaryl (AM-a-ril, glimepiride) will soon hit the market. It's from Hoechst Marion Roussel...the same folks who market DiaBeta (glyburide).

Amaryl works as well as glyburide.

The company will claim that Amaryl is safer...less hypoglycemia. But the jury is still out about whether this is significant.

Get concise advice on drug therapy, plus unlimited access to CE

Pharmacist's Letter includes:

  • 12 issues every year, with brief articles about new meds and hot topics
  • 300+ CE courses, including the popular CE-in-the-Letter
  • Quick reference drug comparison charts
  • Access to the entire archive

Already a subscriber? Log in

Volume pricing available. Get a quote